… dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative …

S Kohsaka, T Murata, N Izumi, J Katada… - … medical research and …, 2017 - Taylor & Francis
warfarin in Japan. The objective of this study is to compare the bleeding risk among patients
… newly prescribed warfarin in Japan using a national wide administrative claim database. …

… of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data

S Kohsaka, J Katada, K Saito… - … Medical Research and …, 2018 - Taylor & Francis
… of NOACs such as apixaban, dabigatran and rivaroxaban in the real… risk of any and major
bleeding was found in the apixaban … of patients, and frequent low-dose apixaban patients were …

[HTML][HTML] Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis

Y Koretsune, T Yamashita, M Yasaka, Y Ono… - Journal of …, 2019 - Elsevier
… In a comparative safety study using Japanese administrative databases, … Bleeding risk of
apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients

Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation

YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - Am Heart Assoc
… Baseline covariates were referred to any claim record with the … with a lower risk of major
bleeding than rivaroxaban. … Our findings in ≈88% of patients taking lowdose dabigatran in …

… anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data

S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open …, 2020 - openheart.bmj.com
… of apixaban, dabigatran, edoxaban and rivaroxaban, each … the risk of ICH, stroke/SE and
major bleeding versus warfarin.… - and low-dose rivaroxaban in Asians with atrial fibrillation. J Am …

[HTML][HTML] Direct comparison of low-dose dabigatran and rivaroxaban for effectiveness and safety in patients with non-valvular atrial fibrillation

SW Meng, TT Lin, MT Liao, HM Chen… - Acta Cardiologica …, 2019 - ncbi.nlm.nih.gov
… -inferiority of low-dose rivaroxaban compared with warfarin was … incidence of gastrointestinal
hemorrhage in our rivaroxaban cohort. … Third, our study did not include apixaban. Although …

… and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation―A Retrospective Chart Review Study …

Y Koretsune, H Hoshino, Y Matsuo, T Ibuki… - Circulation …, 2022 - jstage.jst.go.jp
claims data from acute care hospitals in Japan. Although … ; were taking warfarin, apixaban,
dabigatran, rivaroxaban, or … on the index date; had major bleeding, stroke/SE, or transient …

Thromboembolic, bleeding, and mortality risks of rivaroxaban and dabigatran in Asians with nonvalvular atrial fibrillation

YH Chan, CT Kuo, YH Yeh, SH Chang, LS Wu… - Journal of the American …, 2016 - jacc.org
… the NOACs dabigatran and rivaroxaban versus warfarin in a … In contrast, our analyses
indicated that low-dose NOACs can … GI bleeding than dabigatran (n = 20,963) and apixaban (n = …

The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation

HF Lee, YH Chan, HT Tu, CT Kuo, YH Yeh… - International journal of …, 2018 - Elsevier
rivaroxaban to those of warfarinrisk of intracranial hemorrhage [3]. The introduction of
non-vitamin K antagonist oral anticoagulants (NOACs) like dabigatran, rivaroxaban, apixaban, …

Comparative effectiveness and safety of dabigatran and rivaroxaban in atrial fibrillation patients

CL Lai, HM Chen, MT Liao, TT Lin… - Journal of the American …, 2017 - Am Heart Assoc
… collected 3425 patients with lowdose rivaroxaban (10‐15 mg … Finally, apixaban was not
reimbursed by the Taiwan NHI … warfarin in Japanese patients with atrial fibrillation—the J‐…